Jean Nichols
Geen lopende functies
Loopbaan van Jean Nichols
Eerdere bekende functies van Jean Nichols
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | President | - | 26-04-2011 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Stonegate Partners LLC
 Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Operationeel Directeur | - | - |
Seragen, Inc.
 Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | President | - | - |
Opleiding van Jean Nichols
| The University of North Carolina at Charlotte | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| President | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
Stonegate Partners LLC
Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Finance |
- Beurs
- Insiders
- Jean Nichols
- Ervaring
